{{Rsnum
|rsid=2179965
|Chromosome=1
|position=88336329
|Orientation=plus
|GMAF=0.197
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.3 | 22.1 | 3.5
| HCB | 59.3 | 39.3 | 1.5
| JPT | 39.6 | 46.8 | 13.5
| YRI | 70.1 | 27.9 | 2.0
| ASW | 73.7 | 24.6 | 1.8
| CHB | 59.3 | 39.3 | 1.5
| CHD | 54.1 | 37.6 | 8.3
| GIH | 82.2 | 17.8 | 0.0
| LWK | 65.1 | 30.3 | 4.6
| MEX | 55.2 | 36.2 | 8.6
| MKK | 74.2 | 22.6 | 3.2
| TSI | 85.3 | 12.7 | 2.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2179965
|PubMedID=17903297
|Condition=Cognitive test performance
|Gene=Intergenic
|Risk Allele=
|pValue=1.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PMID|17903297|OA=1
}} non sig. gwas, top 25 GEE p-values, measure of attention and executive function

{{PharmGKB
|RSID=rs2179965
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903297; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study (Initial Sample Size: 705 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Cognitive test performance.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356438
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2179965
|overall_frequency_n=32
|overall_frequency_d=128
|overall_frequency=0.25
|n_genomes=23
|n_genomes_annotated=0
|n_haplomes=28
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}